K. Yaekura et al., CAMP-SIGNALING PATHWAY ACTS IN SELECTIVE SYNERGISM WITH GLUCOSE OR TOLBUTAMIDE TO INCREASE CYTOSOLIC CA2-CELLS( IN RAT PANCREATIC BETA), Diabetes, 45(3), 1996, pp. 295-301
Citations number
39
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
cAMP and the insulinotropic peptides that raise cAMP glucose-dependent
ly increase the cytosolic free Ca2+ concentration ([Ca2+](i)) in pancr
eatic beta-cells, which is tightly linked to the potentiation of gluco
se-induced insulin release. me examined whether cAMP increases [Ca2+](
i) in specific cooperation only with glucose or also with other insuli
n secretagogues that act through different mechanisms. [Ca2+](i) in si
ngle rat pancreatic beta-cells was measured by dual-wavelength fura-2
microfluorometry. In the presence of a stimulatory concentration of gl
ucose (8.3 mmol/l) and the moderate elevation in [Ca2+](i) induced by
it, forskolin, an activator of adenylyl cyclase, or dibutyryl cAMP pro
duced a marked additional increase in [Ca2(+)](i) but was ineffective
at the basal 2.8 mmol/l glucose. These cAMP-elevating agents also pote
ntiated the effect of tolbutamide on [Ca2+](i). The cAMP-induced incre
ase in [Ca2+](i) was completely and selectively inhibited by a blocker
of cAMP-dependent protein kinase A (PKA), and by nitrendipine, a bloc
ker of the L-type Ca2+ channel. However, in the presence of high KCl a
nd the [Ca2+](i) elevation induced by it, a rise in cAMP failed to fur
ther increase [Ca2+](i), whereas BAY K8644, an agonist of L-type Ca2channels, evoked an additional increase in [Ca2+](i). Under low Na+ co
nditions, the [Ca2+](i) response to cAMP was observed in the majority
of the cells. In the cells in which glucose at 4.5-5 mmol/l was inadeq
uate to increase [Ca2+](i), the glucose together with a rise in cAMP o
ften increased [Ca2+](i). Likewise, tolbutamide and a rise in cAMP act
ed in concert to increase [Ca2+](i). Thus, cAMP left-shifted the conce
ntration-[Ca2+](i) response relationship for glucose and tolbutamide.
In conclusion, the cAMP-PKA pathway acts in selective synergism with g
lucose and tolbutamide to initiate [Ca2+](i) signals in pancreatic bet
a-cells. cAMP appears to regulate beta-cell sensitivity to glucose and
tolbutamide. In contrast, cAMP fails to cooperate with high KCl to in
crease [Ca2+](i). It is suggested that cAMP acts mainly on a site that
is more proximal but functionally linked to the L-type Ca2+ channel,
thereby finally increasing Ca2+ flux through this channel.